WSAZ-TV |
Mylan CEO: 'Misconception' about EpiPen profits
USA TODAY Udow-Phillips said that even with the generic version releasing, Mylan will reap significant profits. "I do not think her testimony will persuade many people that Mylan's pricing decisions were appropriate," she said. Follow USA TODAY reporter Nathan ... USA Today reports Gayle Manchin used position to boost EpiPen sales Mylan CEO's mother used position with education group to boost EpiPen sales nationwide Reviewing the Rising Price of EpiPens - United States House Committee on Oversight and Government Reform |
